With reports that the House Democratic leadership has agreed to hearings on Medicare for All, and a Harvard/Politico survey demonstrating that 84 percent of Democrats support a tax-funded national healthcare plan, the concept of Medicare for All is moving into the healthcare debate. At this point, however, Medicare for All is a concept defined by only general terms.

The Medical Advertising Hall of Fame honored 2019 inductees Carol DiSanto and Charlene Prounis on Feb. 7th at The Pierre in New York City.

The threatened “pharma marketing tax” may be back in play during 2019, at both the federal and state levels.

Across every industry, all eyes are on the customer experience. And now, even that is being upleveled by journey orchestration – a concept that focuses on creating a seamless, deeply personalized, end-to-end customer experience – across every channel.

The pharmaceutical industry is embracing a more patient-centric approach throughout the drug development and commercialization value chain. As patients become more involved in their care and evaluate options available to them, pharma organizations are working on new care models to work more closely with the patients and not just with physicians, healthcare organizations and payers.

The U.S. Department of Health and Human Services (HHS) is considering proposing a plan that has many moving parts, one of which could potentially take the price that Medicare pays out to providers for Medicare Part B drugs and turn it on its head.

The talent and tenacity of immigrants can help drive the life sciences industry into the future, if we have the will and the wisdom to encourage it.

Greater Than One has repositioned itself, with a new vision. The agency now identifies itself as “the Health & Wellness Imagination Agency,” according to Kieran Walsh, president of Greater Than One.

McCann Health named Matt Eastwood as global chief creative officer of McCann Health

Precision for Value – part of Precision Value & Health – launched the Value Transformation Practice, which executives describe as a novel initiative to equip life sciences companies with actionable strategies, solutions and partnerships to succeed in an increasingly value-based healthcare environment. Leading the new practice is Maureen Hennessey, Ph.D., CPCC, CPHQ, who was promoted to senior VP, director of value transformation.